ITEOS THERAPEUTICS IN
9.8000
07-October-24 15:59:54
15 minutes delayed
Stocks
-0.2200
-2.20%
Today's range
9.6550 - 10.2200
ISIN
N/A
Source
NASDAQ
-
iTeos to Participate in Upcoming Investor Conferences
28 Aug 2024 16:30:00 By Nasdaq GlobeNewswire
-
20 Aug 2024 08:30:55 By Nasdaq GlobeNewswire
-
iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates
08 Aug 2024 07:00:01 By Nasdaq GlobeNewswire
-
iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
05 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
08 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
10 May 2024 08:26:01 By Nasdaq GlobeNewswire
-
iTeos Therapeutics Announces $120 Million Registered Direct Offering
10 May 2024 08:24:05 By Nasdaq GlobeNewswire
-
07 Apr 2024 16:30:00 By Nasdaq GlobeNewswire
-
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
06 Mar 2024 07:01:00 By Nasdaq GlobeNewswire
-
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
iTeos to Participate in Upcoming Investor Conferences
01 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
08 Jan 2024 07:00:01 By Nasdaq GlobeNewswire
-
iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
21 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
07 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
iTeos to Participate in Upcoming Investor Conferences
06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates
08 Aug 2023 07:00:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >